The biotransformation, excretion, and distribution of the anticholinergic quaternary ammonium compound benzomethamine [N-diethylaminoethyl-N'-methyl-benzilamide methobromide (MC 3199)] and its tertiary amine analogue (MC 3137) and related compounds in animals.
D000588:Amines; D000818:Animals; D001692:Biological Transport; D001711:Biotransformation; D018680:Cholinergic Antagonists; D010276:Parasympatholytics / Q000378:metabolism*; D000644:Quaternary Ammonium Compounds
D000588:Amines; D018680:Cholinergic Antagonists; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; C006705:benzomethamine
PARASYMPATHOLYTICS/metabolism